VectivBio (VECT) Institutional Ownership $16.85 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for VectivBio (NASDAQ:VECT)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$8.09MNumber ofInstitutional Sellers(last 12 months)0 Get VECT Insider Trade Alerts Want to know when executives and insiders are buying or selling VectivBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VECT Institutional Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. VectivBio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/23/2024 Regency Capital Management Inc. DE510,000$8.59M5.5%+1,600.0%0.000% 8/22/2023CHI Advisors LLC2,782,756$46.95M14.2%-47.1%0.000% 8/14/2023Ergoteles LLC443,928$7.49M0.4%N/A0.000% 8/14/2023 EHP Funds Inc.170,000$2.87M0.7%N/A0.000% 8/14/2023 Hunting Hill Global Capital LLC63,581$1.07M0.3%N/A0.000% 8/14/2023 Prelude Capital Management LLC219,643$3.71M0.2%N/A0.000% Get the Latest News and Ratings for VECT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VectivBio and its competitors with MarketBeat's FREE daily newsletter. 8/14/2023 Chicago Capital Management LLC173,840$2.96M3.8%N/A0.000% 8/11/2023 Hsbc Holdings PLC562,022$9.48M0.0%N/A0.000% 8/10/2023 Gardner Lewis Asset Management L P642,769$10.84M3.9%N/A1.889% 8/10/2023 Alpine Associates Management Inc.1,806,697$30.71M1.4%N/A5.311% 8/7/2023 Wolverine Asset Management LLC33,426$564K0.0%N/A0.000% 8/7/2023 Versor Investments LP1,210,379$20.42M3.5%N/A0.000% 8/7/2023 New York Life Investment Management LLC135,051$2.28M0.0%N/A0.000% 8/3/2023 Picton Mahoney Asset Management100,000$1.70M0.1%N/A0.000% 8/1/2023 Regency Capital Management Inc. DE30,000$506K0.4%-21.1%0.000% 7/27/2023Virtu Financial LLC41,411$699K0.1%N/A0.000% 7/27/2023 GAM Holding AG27,545$465K0.0%N/A0.000% 7/20/2023 Harvest Management LLC45,817$779K0.7%N/A0.135% 7/20/2023 Exchange Traded Concepts LLC8,512$144K0.0%N/A0.000% 5/11/2023CHI Advisors LLC5,255,484$44.72M11.9%-4.3%0.000% 5/10/2023Tekla Capital Management LLC682,834$5.87M0.2%-7.4%0.000% 5/8/2023 Regency Capital Management Inc. DE38,000$323K0.4%N/A0.000% 2/14/2023 VR Adviser LLC1,866,000$16.17M2.6%N/A5.487% 2/14/2023 Driehaus Capital Management LLC1,716,656$14.78M0.2%+100.8%5.048% 2/13/2023 Vivo Capital LLC2,333,300$20.22M2.3%N/A6.861% 2/10/2023Tekla Capital Management LLC737,704$6.35M0.2%-2.5%2.169% 2/8/2023 UBS Group AG253,877$2.20M0.0%-2.4%0.746% 2/3/2023 Frazier Life Sciences Management L.P.1,333,400$11.48M0.7%N/A3.920% 11/15/2022 Citadel Advisors LLC3,145,251$18.87M0.0%+0.1%9.248% 11/14/2022 Cormorant Asset Management LP2,536,617$15.22M1.1%-10.7%7.457% 11/14/2022 Caxton Corp140,863$845K1.6%-27.6%0.414% 11/3/2022 Barclays PLC7,807$47K0.0%N/A0.023% 10/13/2022 National Bank of Canada FI165,333$992K0.0%N/A0.486% 8/16/2022 Driehaus Capital Management LLC865,229$4.67M0.1%+120.0%2.544% 8/15/2022 Caxton Corp194,577$1.05M1.4%N/A0.572% 2/3/2022 Canaan Partners XI LLC37,051$182K0.0%N/A0.109% 11/16/2021CHI Advisors LLC2,592,602$20.03M5.8%+0.3%7.622% 11/16/2021 Citadel Advisors LLC2,721,363$20.73M0.0%-0.2%8.000% 11/15/2021 Caas Capital Management LP22,565$174K0.0%-45.1%0.066% 8/17/2021 Woodline Partners LP86,596$1.01M0.0%N/A0.255% New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now!8/17/2021 Millennium Management LLC95,214$1.11M0.0%N/A0.280% 8/17/2021 PFM Health Sciences LP611,074$7.13M0.2%N/A1.796% 8/17/2021 Caas Capital Management LP41,096$479K0.0%N/A0.121% 8/17/2021 Citadel Advisors LLC2,725,767$31.24M0.0%N/A8.013% 8/16/2021 Squarepoint Ops LLC25,000$292K0.0%N/A0.073% 8/16/2021Pinz Capital Management LP30,561$356K0.1%N/A0.090% 8/13/2021 Northern Trust Corp7,159$83K0.0%N/A0.021% 8/13/2021Tekla Capital Management LLC145,000$1.69M0.1%N/A0.426% 8/13/2021 Geode Capital Management LLC17,780$207K0.0%N/A0.052% 8/12/2021 Monashee Investment Management LLC54,466$635K0.1%N/A0.160% 8/11/2021CHI Advisors LLC2,585,986$30.15M7.0%N/A7.602% (Data available from 1/1/2016 forward) VECT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VECT shares? During the previous two years, 24 institutional investors and hedge funds held shares of VectivBio. The most heavily invested institutionals were CHI Advisors LLC ($46.95M), Alpine Associates Management Inc. ($30.71M), Versor Investments LP ($20.42M), Vivo Capital LLC ($20.22M), VR Adviser LLC ($16.17M), Driehaus Capital Management LLC ($14.78M), and Frazier Life Sciences Management L.P. ($11.48M).Learn more on VECT's institutional investors. Which institutional investors have been buying VectivBio stock? Of the 21 institutional investors that purchased VectivBio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($2.33M), VR Adviser LLC ($1.87M), Alpine Associates Management Inc. ($1.81M), Frazier Life Sciences Management L.P. ($1.33M), Versor Investments LP ($1.21M), Driehaus Capital Management LLC ($861.92K), and Gardner Lewis Asset Management L P ($642.77K). How much institutional buying is happening at VectivBio? Institutional investors have bought a total of 12,597,242 shares in the last 24 months. This purchase volume represents approximately $159.72M in transactions. Which VectivBio major shareholders have been selling company stock? The following institutional investors have sold VectivBio stock in the last 24 months: CHI Advisors LLC ($2.71M), Tekla Capital Management LLC ($73.67K), Regency Capital Management Inc. DE ($8K), and UBS Group AG ($6.29K). How much institutional selling is happening at VectivBio? Institutional investors have sold a total of 2,798,095 shares in the last 24 months. This volume of shares sold represents approximately $44.55M in transactions. Related Companies WVE Major Shareholders KROS Major Shareholders CGON Major Shareholders AMPH Major Shareholders AKRO Major Shareholders MIRM Major Shareholders CNTA Major Shareholders APGE Major Shareholders HRMY Major Shareholders IRON Major Shareholders This page (NASDAQ:VECT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.